v3.24.1.u1
Financial Statements Details (Tables)
 3 Months Ended
Mar. 31, 2024
Balance Sheet Components [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash The reconciliation of cash, cash equivalents and restricted cash reported on the unaudited condensed consolidated balance sheets to the total of the same such amounts in the unaudited condensed consolidated statements of cash flows is as follows (in thousands):
March 31, 2024December 31, 2023
Cash and cash equivalents$2,092,101 $1,938,606 
Restricted cash included in other assets860 858 
 Total cash, cash equivalents and restricted cash$2,092,961 $1,939,464 
Schedule of Accounts Receivable, Net Accounts receivable, net consists of the following (in thousands):
March 31, 2024December 31, 2023
Accounts receivable $1,098,983 $1,034,480 
Product sales rebate and returns reserve(8,942)(9,911)
   Accounts receivable, net $1,090,041 $1,024,569 
Schedule of Inventories Inventories consist of the following (in thousands):
March 31, 2024December 31, 2023
Raw materials $979,947 $930,777 
Finished goods 1,045,257 1,014,403 
   Total inventories $2,025,204 $1,945,180 
Schedule of Property and Equipment, Net Property and equipment, net consists of the following (in thousands):
March 31, 2024December 31, 2023
Land$45,160 $44,645 
Equipment and machinery 152,410 144,850 
Computer hardware and software 58,448 57,761 
Leasehold improvements
34,706 34,584 
Furniture and fixtures 3,563 3,576 
Construction-in-process 338 4,242 
    Property and equipment, gross 294,625 289,658 
Less: accumulated depreciation (196,676)(188,078)
    Property and equipment, net $97,949 $101,580 
Schedule of Accrued Liabilities Accrued liabilities consist of the following (in thousands):
March 31, 2024December 31, 2023
Accrued compensation-related costs$62,920 $134,225 
Accrued supplier liability95,392 167,878 
Accrued manufacturing costs61,036 61,491 
Accrued product development costs10,063 1,041 
Other41,175 42,667 
   Total accrued liabilities $270,586 $407,302 
Schedule of Contract Assets, Contract Liabilities and Deferred Revenue The following table summarizes the activity related to our contract liabilities (in thousands):
Three Months Ended March 31,
20242023
Contract liabilities, beginning balance$133,239 $103,448 
Less: Revenue recognized from beginning balance(12,000)(9,243)
Less: Beginning balance reclassified to deferred revenue(6,498)(4,382)
Add: Contract liabilities recognized24,877 15,224 
Contract liabilities, ending balance$139,618 $105,047 
The following table summarizes the activity related to our deferred revenue (in thousands):
Three Months Ended March 31,
20242023
Deferred revenue, beginning balance
$1,506,204 $1,041,246 
Less: Revenue recognized from beginning balance(284,283)(214,450)
Add: Deferral of revenue in current period, excluding amounts recognized during the period441,321 265,478 
Deferred revenue, ending balance$1,663,242 $1,092,274 
Schedule of Other Income (Expense), Net Other income (expense), net consists of the following (in thousands):
Three Months Ended March 31,
20242023
Interest income$63,823 $22,509 
 Gain (loss) on strategic investments— (5,571)
Other income (expense), net(1,203)(4,792)
    Total$62,620 $12,146